Association of p155/140 Autoantibody With Loss of Nailfold Capillaries but not Generalized Lipodystrophy: A Study of Ninety‐Six Children With Juvenile Dermatomyositis

Myositis‐specific antibodies (MSAs) facilitate grouping children with juvenile dermatomyositis (DM) into distinct phenotypes. The first aim of this study was to investigate the link between anti‐p155/140 and lipodystrophy as determined by dual x‐ray absorptiometry (DXA) assessment of fat distribution. The second aim was to examine the relationship between anti‐p155/140 and damage to the nailfold capillary system.

[1]  Yoshiya Tanaka,et al.  Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies , 2018, Rheumatology.

[2]  L. Pachman,et al.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity. , 2018, The Journal of pediatrics.

[3]  G. Shaddick,et al.  Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort , 2017, Journal of autoimmunity.

[4]  E. Martinez,et al.  Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance , 2012, BMC Infectious Diseases.

[5]  R. Schneider,et al.  Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis. , 2011, Rheumatology.

[6]  P. Blackshear,et al.  Predictors of Acquired Lipodystrophy in Juvenile-Onset Dermatomyositis and a Gradient of Severity , 2008, Medicine.

[7]  L. Pachman,et al.  Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.

[8]  A. Paller,et al.  Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. , 2008, Arthritis and rheumatism.

[9]  L. Wedderburn,et al.  The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. , 2006, Rheumatology.

[10]  V. Szejnfeld,et al.  Bone mineral density of Brazilian girls with juvenile dermatomyositis. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[11]  A. Dyer,et al.  Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops. , 2004, The Journal of rheumatology.

[12]  J. Gatell,et al.  Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  R. Bode,et al.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.

[14]  R. Petty,et al.  Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities. , 2001, The Journal of rheumatology.

[15]  H. Maricq,et al.  Childhood dermatomyositis: serial microvascular studies. , 1989, Pediatrics.